Delphi Automotive PLC has signed a commercial partnership agreement with BlackBerry Ltd. to provide the operating system for its autonomous driving system. Delphi and BlackBerry QNX will collaborate to enhance software performance and safety in their operating system to advance autonomous driving technology.

Delphi's Centralized Sensing Localization and Planning (CSLP), to launch in 2019, is designed to provide car manufacturers and Automated Mobility on Demand (AMoD) a turnkey automated driving solution. The BlackBerry QNX OS for Safety will facilitate Delphi's proprietary Ottomatika software algorithms and middleware, to enhance performance and safety.

"BlackBerry QNX will provide a robust software infrastructure for CSLP and help advance Delphi's autonomous driving system," said Glen De Vos, Delphi Senior Vice President and Chief Technology Officer. "Safety in high-performance computing systems is paramount to a production-ready autonomous driving solution."

"There is no safety without security," said John Wall, SVP and GM of BlackBerry QNX. "With cyberattacks and threats to connected vehicles on the rise, it is imperative that auto manufacturers are provided with software that is safety certified, reliable, and secure. This is an area in which BlackBerry QNX excels, and we look forward to the new opportunities this expansion with Delphi will bring."

QNX SDP 7.0 is designed to provide high-performance and enhanced kernel-level security through features including microkernel architecture, file encryption, adaptive time partitioning, a high availability framework, anomaly detection, and multi-level policy-based access control. BlackBerry QNX's OS reportedly helps guard against system malfunctions, malware, and cyberattacks by implementing a multi-level, policy-driven security model that incorporates security technology from BlackBerry. The OS is also certified to ISO 26262 ASIL D (the highest level achievable) for automobiles and to IEC 61508 SIL 3 for industrial automation systems, and by compliance with IEC 62304 for life-critical Class III medical devices.